Sage Journals: Discover world-class research

Open access

Review article

First published 2023-3

Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis

Roberta Messina, Eva-Maria Huessler, Francesca Puledda [...]

Cephalalgia

Open access

Brief report

First published 2024

Rimegepant as an acute treatment in a refractory migraine patient non-responder to two anti-CGRP monoclonal antibodies and triptans: Case report and pharmacological considerations

Andrea Burgalassi, Giulia Vigani, Alberto Boccalini [...]

Cephalalgia Reports

Open access

Review article

First published 2023-4

Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials

Faraidoon Haghdoost, Francesca Puledda, David Garcia-Azorin [...]

Cephalalgia

Free access

Review article

First published 2019-3

CGRP – a target for acute therapy in migraine: Clinical data

Roberta Messina, Peter J Goadsby

Cephalalgia

Free access

Review article

First published 2019-3

Recognizing the role of CGRP and CGRP receptors in migraine and its treatment

Lars Edvinsson, Karin Warfvinge

Cephalalgia

Free access

Research article

First published 2020-4

Characterisation of the calcitonin gene-related peptide receptor antagonists ubrogepant and atogepant in human isolated coronary,cerebral and middle meningeal arteries

Eloísa Rubio-Beltran, Ka Yi Chan, AH Jan Danser [...]

Cephalalgia

Open access

Research article

First published 2025-11

Biodistribution of atogepant and rimegepant in mouse peripheral and central structures of relevance to migraine pathogenesis

Alessandra Pistolesi, Francesco De Cesaris, Daniela Buonvicino [...]

Cephalalgia

Open access

Review article

First published 2023-2

New migraine prophylactic drugs: Current evidence and practical suggestions for non-responders to prior therapy

Mi Ji Lee, Mohammad Al-Mahdi Al-Karagholi, Uwe Reuter

Cephalalgia

Open access

Research article

First published 2020-3

Ubrogepant: The First Gepant to Pass Food and Drug Administration for Acute Migraine

Sivagourounadin Kiruthika, Rajendran Priyadharsini

Journal of Pharmacology and Pharmacotherapeutics

Open access

Review article

First published 2024-3

Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex

Frank Porreca, Edita Navratilova, Joe Hirman [...]

Cephalalgia

Search results